NP-103

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameNP-103
Drug Alias Nameglycogen synthase kinase-3 inhibitor (Neuropharma)NP-060103NP-103NP-60103
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectantsGlycogen synthase kinase-3 inhibitors
TargetsGlycogen synthase kinase-3
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNoscira Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNoscira Sa
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A